Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

BioStock: Interview with CombiGene's new CMC expert

The Swedish Gene Therapy Company CombiGene aims to complete its preclinical program for the epilepsy project CG01 this year, in order to begin studies in humans in 2022. In this transitional phase, CombiGene has accelerated its recruitment process to occupy several key positions. BioStock has spoken with the newly recruited CMC expert Martin Linhult who, with his long experience of bringing pharmaceuticals to the market, will primarily focus on the manufacturing process of CG01.Read the full interview with Martin Linhult at biostock.se:  https://www.biostock.se/en/interview-with-

KHK Capital secures £25m funding facility to support growth

Property bridging and development lender, KHK Capital, has secured a £25 million funding line fromUK savings and lending specialist, Shawbrook Bank.The new financing line enables KHK Capital to meet rapidly growing demand from new and repeat customers for lending solutions on a diverse range of residential and commercial property.   "KHK Capital has been a 'family office' working mostly with private funds for a number of years," said Andy Kent, founding partner of KHK Capital. "We are very pleased to have secured this financing through Shawbrook Bank at a time when we are

IFS to propel major transformation project for India’s largest defense manufacturer

Comprehensive ERP solution from IFS to be rolled out in collaboration with Tech Mahindra to 9,500 users, working at multiple divisions across IndiaLondon and Bangalore, January 12, 2021 – IFS , the global enterprise applications company, has signed a contract with Tech Mahindra , a leading provider of digital transformation, consulting and business reengineering services and solutions and the prime contractor for Hindustan Aeronautics Limited (HAL), to enable HAL ’s Project Parivartan Program, a US$ 54 million (

Swedbank Robur launches new policy and sharpens its strategies to opt out fossil fuels

Swedbank Robur's Policy for responsible investments has been updated and supplemented with three new strategies for exclude, include and engage, which will be applied to the company’s various fund types. Swedbank Robur's Climate Strategy was also revised during the year and sharpened further. In line with this, the fund company has per January 1[st], 2021, decided to expand its strategy to exclude fossil fuels to also encompass oil and gas in addition to coal¹.Swedbank Robur has updated its Policy for responsible investments by expanding its strategy for opting out of fossil fuels to

Q-Free: Share capital increase registered

Reference is made to stock exchange releases 5 January 2021, 6 January 2021 and 7 January 2021 related to conversion notices for the subordinated Convertible Bond Loan issued by Q-Free ASA 18 May 2020. The share capital increase has now been registered in the Norwegian Register of Business Enterprises. Q-Free ASA’s new share capital is NOK 40,913,083.80 divided into 107,666,010 shares with a par value of NOK 0.38 per share. Each share gives one vote at the Company’s general meeting. The new shares will be issued on a separate ISIN until a listing prospectus for the new shares has

IRLAB presents application of deep learning on multidimensional CNS drug efficacy data

IRLAB (Nasdaq Stockholm: IRLAB A) presents results from a collaboration between the Department of Mathematical Sciences at Chalmers University of Technology, Gothenburg, the specialist artificial intelligence (AI) company Smartr and IRLAB. Based on multidimensional in vivo phenotypic dose response profiles generated by IRLAB's ISP technology, it is found that in particular multilayer perceptron networks perform well for prediction of therapeutic indication and classification of drug candidates. The methodology further holds promise to discover new or expanded indications for both drug

NOTIFICATION OF MANAGERS’ AND CLOSELY RELATED PARTIES’ TRANSACTIONS WITH DAMPSKIBSSELSKABET NORDEN A/S’ SHARES IN CONNECTION WITH SHARE BUY-BACK PROGRAM

ANNOUNCEMENT NO. 9 - 12 JANUARY 2021 In connection with the announced share buy-back program in Dampskibsselskabet NORDEN A/S, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcement no. 90/2020. Kind regards, Dampskibsselskabet NORDEN A/S Martin Badsted CFO For further information: Martin Badsted, CFO, tel.: +45 3315 0451

Domainex invests in the Creoptix WAVEdelta to strengthen its fragment-based drug discovery platform

Wädenswil/Zurich, Switzerland, and Saffron Walden, UK, 12 January 2021 – Domainex Ltd. , a leading provider of integrated drug discovery services, is pleased to announce that it has invested in the WAVEdelta instrument from Creoptix AG . This instrument utilizes Grating-Coupled Interferometry  (GCI) to measure target binding on sensor chips, generating binding affinity and on/off rate kinetics in a high throughput manner. This system achieves superior

Invitation to presentation of Humana's report on fourth quarter and full year 2020

Humana's interim report for the fourth quarter and the full year 2020 results will be published at 08:00 CET on February 11, 2021. A web-cast telephone conference will be held at 09:00 CET the same day.The webcast, where CEO and President Rasmus Nerman and CFO Noora Jayasekara will present the report, will be accessible at Humana's website www.humanagroup.com. The presentation material will be published on the website before the conference starts. The webcast, and later the recorded version of the webcast, will also be available at www.financialhearings.com. To participate in the

Beactica Therapeutics and University of Dundee announce collaboration to develop WRN inhibitors to target cancer

Beactica Therapeutics AB, the Swedish drug discovery company, and University of Dundee, a top-ranked university in the UK for biological sciences, today announced a new research collaboration agreement. The two parties will work together in a project aimed at inhibiting WRN helicase, a protein with significant therapeutic potential for cancers with microsatellite instability. The collaboration will leverage core capabilities of each partner and build on the work of Professor John Rouse, on the control of chromosome stability and DNA repair in cancer. Beactica will contribute key

Gothenburg Green City Zone leads the way towards zero-emissions transportation in the near future

Currently in development, Gothenburg Green City Zone is a world first: an initiative by a number of major stakeholders including Volvo Cars to build a climate-neutral transportation system in a large geographical area of Gothenburg. New technology will be tested here to allow this part of Gothenburg to have 100% emission-free transport modes by 2030. And everyone is welcome to join in.Gothenburg and the Gothenburg region are growing, and the number of tourists and other visitors is set to double by 2030. This will bring a steady increase in demand for transportation, while at the same time

Lime Technologies CFO joins Itello Board of Directors

Stockholm, January 12, 2021 – Itello, a leading provider of Policy and Administration Systems and digital solutions for the life and pension insurance industry, has appointed Magnus Hansson to its Board of Directors. Magnus is currently Chief Financial Officer with the business software supplier Lime Technologies. He has previously held the CFO position at European House of Beds AB. Magnus has a Master’s degree from Jönköping International Business School. “Magnus is a welcome addition to our board, and he brings very relevant experience to Itello. We value his perspective on the B2B

Lime Technologies CFO joins Itello Board of Directors

Stockholm, January 12, 2021 – Itello, a leading provider of Policy and Administration Systems and digital solutions for the life and pension insurance industry, has appointed Magnus Hansson to its Board of Directors. Magnus is currently Chief Financial Officer with the business software supplier Lime Technologies. He has previously held the CFO position at European House of Beds AB. Magnus has a Master’s degree from Jönköping International Business School. “Magnus is a welcome addition to our board, and he brings very relevant experience to Itello. We value his perspective on the B2B

NCC to develop and build new headquarters for Genmab at Kontorværket in Copenhagen

The Kontorværket commercial area project developed by NCC occupies a central location in Valby, a district in central Copenhagen. Here, NCC will build Genmab’s new headquarters, which will meet high environmental standards for both the building and the area.[Illustration] Illustration: DISSING+WEITLINGGenmab A/S is a leader in the creation and development of differentiated antibody products for the treatment of cancer, with headquarters in Copenhagen, Denmark. The construction of Genmab’s new headquarters will start in April 2021 and is expected to be ready in the first quarter of 2023.

Finnair introduces one-way ticket fares for its flights within Europe

Finnair brings customers more choice and flexibility by introducing a new, one-way fare structure for its intra-Europe and domestic flights from 12 January 2021. One-way tickets with competitive fares are now available for all Finnair intra-Europe and domestic flights in all purchase channels.  “We want to offer our customers more choice and flexibility, and removing the complexity of return fare rules makes buying simpler and more transparent. Now the best fare levels will be available for all customers regardless of the length of stay in the destination. This is something our customers

The Nomination Committee’s proposal for Chair of the Board

In advance of the Nordic Entertainment Group AB (publ) (“NENT Group”) Annual General Meeting of shareholders to be held on Wednesday 19 May 2021, NENT Group Chair David Chance has decided not to stand for re-election. The NENT Group Nomination Committee proposes the election of Pernille Erenbjerg as the new Chair of the Board. Pernille Erenbjerg has served as member of the NENT Group Board since May 2020, and was previously President and CEO of TDC, a leading provider of integrated communications and entertainment solutions in Denmark and Norway. Pernille is currently Deputy Chair of

Tele2 presents expanded Group Leadership Team

Stockholm – Today Tele2 AB (“Tele2”) (Nasdaq Stockholm: TEL2 A and TEL2 B) presents its expanded Group Leadership Team and announces the appointment of Stefan Trampus as new Executive Vice President Tele2 B2B and Yogesh Malik as new Executive Vice President CTIO.Tele2 presents its expanded Group Leadership Team which will now include two additional members representing key strategic areas. Yogesh Malik has been appointed Executive Vice President CTIO and will lead the new combined technology and IT unit. Yogesh has held many senior roles in multinational companies over the last 15 years

Apotek Hjärtat’s CEO Anders Nyberg retires

Anders Nyberg, CEO of Apotek Hjärtat, has announced his decision to retire during the fall of 2021. ICA Gruppen has initiated the process offinding a successor. Anders Nyberg will continue as CEO of Apotek Hjärtat and member of the group management of ICA Gruppen until his successor is in place.“I would like to extend a warm thank you to Anders Nyberg, who in recent years has developed Apotek Hjärtat from a challenger to a market leader. It is a journey that has included the development of a leading e-commerce, the acquisition of Min Doktor and to utilize the strength of being part of ICA

Meta-analysis updated with DIAGNODE-2 results provides further support for a precision medicine approach using Diamyd[®]

The large scale meta-analysis, previously published in August 2020, based on data from Phase III and Phase II trials in Europe and in the United States with the type 1 diabetes vaccine Diamyd[®] (GAD/alum), has been updated with data from the recenly announced (Sep 2020) European Phase IIb trial DIAGNODE-2. This meta-analysis comprises data from 627 individual patients and provides further support for a positive and statistically significant dose-dependent treatment response on the preservation of endogenous insulin production in individuals with type 1 diabetes that carry the HLA DR3-DQ2

Bactiguard launches Hydrocyn aqua in Greece

Bactiguard continues the launch of the Hydrocyn® aqua (Hydrocyn) product range in Europe by entering a new partnership with Lifecyn S.A. (Lifecyn) in Greece. The collaboration is based on an exclusive distribution agreement for Bactiguard’s Hydrocyn® aqua range, including products for advanced disinfection and wound care.“Launching the Hydrocyn product range in Greece is an important milestone. This is the first European launch since we introduced Hydrocyn in the Swedish market last year. Lifecyn has a proven track record and solid experience in marketing premium healthcare products to the

Kamux continues to expand by opening a mega store in Gothenburg

Kamux Corporation          Press release    12 January, 2021 at 9:30 Kamux continues to expand by opening a mega store in Gothenburg Kamux, a specialist in the purchase and sale of used cars, continues to grow in Sweden by opening a mega store in Gothenburg. “Kamux continues to expand with resolution in Sweden. The Gothenburg store perfectly complements our showroom network, and at the same time it will expand our offering to our customers. I am delighted that with the new store, Kamux will have a prominent presence in Gothenburg, which is the second largest city in Sweden. The

Alfa Laval acquires unique technology to strengthen its position in sustainable beer production

Alfa Laval – a world leader in heat transfer, centrifugal separation and fluid handling – has acquired Sandymount, a US-based beverage technology company with a unique and patented membrane technology to concentrate beer. The technology in combination with Alfa Laval’s extensive product range, will open up interesting business opportunities for the company, and enable a more sustainable beer-delivery supply chain. The signing and closing date was December 31.Sandymount’s patented membrane technology, Revos™, in combination with Alfa Laval’s extensive product range for beer production, will

Latour completes acqui sition of VEGA S.R.L.

On November 17, 2020, Investment AB Latour, through its wholly owned subsidiary Latour Industries AB, signed an agreement to acquire VEGA S.R.L, a company based in the Marche region, Italy. All closing conditions have now been fulfilled and the transaction has been completed as of January 11, 2021. Göteborg, 12 January 2021 INVESTMENT AB LATOUR (PUBL)Johan Hjertonsson, CEO For further information, please contact:Björn Lenander, CEO Latour Industries AB, +46 708 19 47 36Gustav Samuelsson, Business Development Investment AB Latour, +46 735 52 55 59 Latour Industries consists

There are no items matching the current filter
There are no more items matching the current filter
Back to top